predict • partner • prepare
Project PROTECT is a proactive approach to ensure the continuous availability of essential medicines through collaboration and risk-sharing with 503B Outsourcing Facilities. This initiative will work to alleviate the patient impact of shortages for over 100 vital medicines by leveraging onshore manufacturing capabilities. Through prediction technology and partnership PROTECT offers grass roots funded grants to 503B manufacturers who proactively prepare and develop medicines most vulnerable to shortage.
Protect ultimately reinforces resilience, on shore flexiblity, supply readiness and capacity and stabilizes the drug supply chain for patient care. Project PROTECT was awarded the CNN 2023 Champion for Change Award. See the video here.
“In the process, she [Laura Bray] started a movement. She is now channeling what she learned into a national effort to predict which drugs will go into shortage and to produce them before patients have to go without”
CURRENT PROJECTS Available
We are currently accepting grant applications for project PROTECT to protect the following Essential Medicines from drug shortage. The term for 2024 for PROTECT represents a three-year commitment to one or more of the ten (10) Essential Medicines. This commitment is a key part of our strategy to fortify healthcare supply chain resiliency while we protect and mitigate essential medicines from shortages. For more information, please contact us at Anthonyflammia@angelsforchange.org.
PROJECTS in development
PROJECTS PROTECTED
Below is a list of drugs that have been protected with the help of our Change Makers. Over 750,000 treatments have been accessed so far.
Thank you to our 2023 Project PROTECTORS
for protecting patient lives!
“We are pleased to see the immediate impact this pilot has created for our hospitals. Children’s hospitals have been able to provide needed TPN and other life-saving electrolyte therapies during a time of urgent shortage. The net new supply has enabled our hospitals to ensure uninterrupted care for vulnerable patients.”
February 2022
Angels for Change announced their first grant recipient to STAQ Pharma, Inc. which increased capacity and supply resulting in more 750,000 life-saving treatments.
